InvestorsHub Logo

Couch

11/12/15 5:25 AM

#172251 RE: Jimmy Joe #172249

It seems this little article (See Below) here has created quite a stir around here. It seems the premise of the article states what Nasrat has said so clearly long ago. The FDA likes the pharmacologic approach to ADT the best. While the doctors weren't working for the FDA it does highlight that most doctors prefer to prescribe an ADT that actually works.

What I find hilarious is trying to over emphasize 69% of the doctors out there wouldn't prescribe Elite's ADT. As I stated earlier, that is laughable LOL LOL at best. Clearly, when given a choice the majority of doctors are going to choose to prescribe the ADT approach that ELTP uses.

Physicians call for novel abuse-deterrent opioid agonist/antagonist formulations in survey



http://www.fiercedrugdelivery.com/story/physicians-call-novel-abuse-deterrent-opioid-agonistantagonist-formulations/2015-11-09

A survey of more than 200 physicians found that 31% think opioid antagonists is the abuse-deterrent formulation that is most needed to combat the opioid abuse epidemic--an issue that's been implicated in the startling rise of the death rate of middle-aged white Americans without a college degree.

What type of abuse- deterrent formulation is most needed?

Number (out of 214 respondents)

Opioid antagonist/agonist combination 66 (31%)
Physical or chemical barrier 48 (22%)
Novel delivery system 34 (16%)
Aversion 33 (15%)
Prodrug 14 (7%)
Other or combination of above 19 (9%)